4
Changes in Ownership
Adicet Bio, Inc. Filed Acc 0001209191-23-046101
Options or other derivatives
- Chief Scientific Officer acquired 408,812 shares (grant or award)
- Chief Scientific Officer returned 408,812 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | D: show line 1 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | D: show line 2 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Returned to the company · Stock Option (Right to Buy) | −56,612 | 0 | D: show line 3 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Grant or award · Stock Option (Right to Buy) | +56,612 | 56,612 | D: show line 4 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | D: show line 5 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D: show line 6 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Returned to the company · Stock Option (Right to Buy) | −60,000 | 0 | D: show line 7 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | D: show line 8 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Returned to the company · Stock Option (Right to Buy) | −117,200 | 0 | D: show line 9 in the form | ||
| Aftab Blake Chief Scientific Officer | 2023-08-14 | Grant or award · Stock Option (Right to Buy) | +117,200 | 117,200 | D: show line 10 in the form |
Loading xslF345X05/doc4.xml…